These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Protective Immunity Against Homologous and Heterologous Influenza Virus Lethal Challenge by Immunization with New Recombinant Chimeric HA2-M2e Fusion Protein in BALB/C Mice. Ameghi A, Pilehvar-Soltanahmadi Y, Baradaran B, Barzegar A, Taghizadeh M, Zarghami N, Aghaiypour K. Viral Immunol; 2016 May; 29(4):228-34. PubMed ID: 27058011 [Abstract] [Full Text] [Related]
7. Antibodies specific to the HA2 glycopolypeptide of influenza A virus haemagglutinin with fusion-inhibition activity contribute to the protection of mice against lethal infection. Gocník M, Fislová T, Sládková T, Mucha V, Kostolanský F, Varečková E. J Gen Virol; 2007 Mar; 88(Pt 3):951-955. PubMed ID: 17325369 [Abstract] [Full Text] [Related]
10. Evaluation of the immunogenicity and protective effects of a trivalent chimeric norovirus P particle immunogen displaying influenza HA2 from subtypes H1, H3 and B. Gong X, Yin H, Shi Y, He X, Yu Y, Guan S, Kuai Z, Haji NM, Haji NM, Kong W, Shan Y. Emerg Microbes Infect; 2016 May 25; 5(5):e51. PubMed ID: 27222326 [Abstract] [Full Text] [Related]
14. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design. Liu WC, Jan JT, Huang YJ, Chen TH, Wu SC. J Virol; 2016 Oct 01; 90(19):8496-508. PubMed ID: 27440889 [Abstract] [Full Text] [Related]
15. Targeting the HA2 subunit of influenza A virus hemagglutinin via CD40L provides universal protection against diverse subtypes. Fan X, Hashem AM, Chen Z, Li C, Doyle T, Zhang Y, Yi Y, Farnsworth A, Xu K, Li Z, He R, Li X, Wang J. Mucosal Immunol; 2015 Jan 01; 8(1):211-20. PubMed ID: 25052763 [Abstract] [Full Text] [Related]
17. Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine. Tsybalova LM, Stepanova LA, Shuklina MA, Mardanova ES, Kotlyarov RY, Potapchuk MV, Petrov SA, Blokhina EA, Ravin NV. PLoS One; 2018 Jan 01; 13(8):e0201429. PubMed ID: 30138320 [Abstract] [Full Text] [Related]
18. Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Wang TT, Tan GS, Hai R, Pica N, Ngai L, Ekiert DC, Wilson IA, García-Sastre A, Moran TM, Palese P. Proc Natl Acad Sci U S A; 2010 Nov 02; 107(44):18979-84. PubMed ID: 20956293 [Abstract] [Full Text] [Related]
19. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype. Walz L, Kays SK, Zimmer G, von Messling V. J Virol; 2018 Sep 01; 92(17):. PubMed ID: 29925654 [Abstract] [Full Text] [Related]
20. Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses. Kwon HI, Kim YI, Park SJ, Song MS, Kim EH, Kim SM, Si YJ, Lee IW, Song BM, Lee YJ, Yun SJ, Kim WJ, Choi YK. J Virol; 2017 Jun 01; 91(11):. PubMed ID: 28331080 [Abstract] [Full Text] [Related] Page: [Next] [New Search]